EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 212 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2022. The put-call ratio across all filers is 1.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $336,389 | -70.9% | 99,106 | -36.9% | 0.00% | -50.0% |
| Q2 2023 | $1,156,491 | -28.0% | 157,114 | +1.3% | 0.00% | -33.3% |
| Q1 2023 | $1,605,891 | -29.8% | 155,119 | -19.9% | 0.00% | -40.0% |
| Q4 2022 | $2,288,579 | -28.8% | 193,762 | +26.3% | 0.01% | -28.6% |
| Q3 2022 | $3,216,000 | -49.4% | 153,372 | -25.1% | 0.01% | -46.2% |
| Q2 2022 | $6,351,000 | +62.0% | 204,737 | +114.4% | 0.01% | +85.7% |
| Q1 2022 | $3,920,000 | +239.1% | 95,484 | +258.4% | 0.01% | +250.0% |
| Q4 2021 | $1,156,000 | -69.7% | 26,641 | -65.0% | 0.00% | -66.7% |
| Q3 2021 | $3,810,000 | -23.1% | 76,110 | -3.2% | 0.01% | -25.0% |
| Q2 2021 | $4,956,000 | +111.0% | 78,623 | +210.4% | 0.01% | +100.0% |
| Q1 2021 | $2,349,000 | +21.2% | 25,328 | +17.6% | 0.00% | 0.0% |
| Q4 2020 | $1,938,000 | -12.0% | 21,532 | +1.0% | 0.00% | -20.0% |
| Q3 2020 | $2,202,000 | +692.1% | 21,314 | +499.0% | 0.01% | +400.0% |
| Q2 2020 | $278,000 | -69.4% | 3,558 | -78.6% | 0.00% | -50.0% |
| Q1 2020 | $909,000 | -61.6% | 16,601 | -62.0% | 0.00% | -50.0% |
| Q4 2019 | $2,369,000 | -45.1% | 43,734 | -47.8% | 0.00% | -50.0% |
| Q3 2019 | $4,314,000 | -17.0% | 83,735 | -22.6% | 0.01% | -20.0% |
| Q2 2019 | $5,200,000 | -28.0% | 108,122 | -25.0% | 0.01% | -23.1% |
| Q1 2019 | $7,220,000 | -33.0% | 144,201 | -21.3% | 0.01% | -45.8% |
| Q4 2018 | $10,778,000 | -11.9% | 183,283 | -1.5% | 0.02% | +4.3% |
| Q3 2018 | $12,234,000 | -19.2% | 186,116 | -37.7% | 0.02% | -28.1% |
| Q2 2018 | $15,148,000 | -49.3% | 298,893 | -47.3% | 0.03% | -37.3% |
| Q1 2018 | $29,854,000 | +40.2% | 567,042 | +27.0% | 0.05% | +41.7% |
| Q4 2017 | $21,300,000 | +15.9% | 446,358 | -1.7% | 0.04% | +16.1% |
| Q3 2017 | $18,370,000 | +22.4% | 454,158 | +2.6% | 0.03% | +14.8% |
| Q2 2017 | $15,010,000 | +12.3% | 442,680 | -3.8% | 0.03% | +8.0% |
| Q1 2017 | $13,366,000 | -9.8% | 460,248 | +3.2% | 0.02% | -13.8% |
| Q4 2016 | $14,824,000 | – | 445,953 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 22,111 | $908,000 | 2.08% |
| Global Alpha Capital Management Ltd. | 460,530 | $18,909,000 | 1.62% |
| AIMZ Investment Advisors, LLC | 70,625 | $2,900,000 | 1.19% |
| Bridge City Capital, LLC | 39,835 | $1,636,000 | 0.76% |
| PALISADE CAPITAL MANAGEMENT, LP | 560,409 | $23,010,000 | 0.53% |
| EARNEST PARTNERS LLC | 2,071,376 | $85,051,000 | 0.50% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,721 | $12,430,000 | 0.50% |
| SummerHaven Investment Management, LLC | 14,476 | $594,000 | 0.34% |
| Ridgewood Investments LLC | 10,004 | $411,000 | 0.27% |
| AtonRa Partners | 11,505 | $472,000 | 0.26% |